GDF3 and metabolic dysfunction-associated steatohepatitis: Thirdly, mechanistic studies using GDF3 knockout and/or transgenic mice, especially cell- or tissue-specific manipulations, would be required to further evaluate the role of GDF3 in NASH progression.